Primo Brands Corporation (NYSE:PRMB) is one of the most promising mid-cap consumer staples stocks under $100.
On January 8, Mizuho reaffirmed its Outperform rating on Primo Brands Corporation (NYSE:PRMB). The firm also lowered the target price for the stock from $28 to $24 as part of their broader revisions across the food production businesses in line with the 2026 outlook. It cited macroeconomic uncertainties and fundamental weakness across businesses as primary factors that will continue to take a toll on potential valuation recoveries.
Copyright: art9858 / 123RF Stock Photo
The firm sees rising trends towards health consciousness, which will prevail during the coming year. However, market fragmentation has now led to intense competition among players, which has kept valuations depressed. Despite the downward revision, Mizuho’s estimates still give an upside of 33% at the current level.
Back on December 18, JPMorgan also lowered its price target for Primo Brands Corporation (NYSE:PRMB) from $23 to $21. However, the firm maintained its Overweight rating on the stock based on its 2026 outlook. Despite forecasting some headwinds in 2026 for beverages, household, and personal care businesses, the firm believes that some of the major issues have already lapped during 2025. Most notable ones include tariffs and issues linked to low-income and Hispanic consumers.
The firm expects strong support for consumption and business profitability, which will result from reduced tariffs and currency movements favoring multinationals. Its forecasted price target leads to around 17% upside potential.
Primo Brands Corporation (NYSE:PRMB) offers purified water and branded beverages and is one of the largest players in North America. They distribute their products through an extensive network of more than 150,000 retail outlets. They also sell through e-commerce, direct-to-consumer, residential, and commercial channels.
While we acknowledge the potential of PRMB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.
Disclosure: None. This article is originally published at Insider Monkey.